InvestmentJul 29, 2026, 05:06 PM
Onconetix Secures $30.25M PIPE Financing via Series F Preferred Stock
AI Summary
Onconetix, Inc. entered into a Securities Purchase Agreement with an accredited investor for a Private Investment in Public Equity (PIPE) financing. The company will issue 37,812 shares of Series F convertible preferred stock for an aggregate purchase price of $30,249,600. Concurrently, a Registration Rights Agreement was executed, obligating Onconetix to register the common stock underlying the Series F Preferred Stock for resale. The Series F Preferred Stock has a stated value of $1,000 per share and an initial conversion price of $0.9767 per common share.
Key Highlights
- Onconetix secured $30,249,600 in PIPE financing from an accredited investor.
- The company issued 37,812 shares of Series F convertible preferred stock.
- Each Series F preferred share has a stated value of $1,000.
- The initial conversion price for common stock is $0.9767 per share.
- Series F Preferred Stock ranks senior to the Company's Common Stock.
- The company entered into a Registration Rights Agreement for the underlying common stock.
Price Impact
More from ONCO